Skip to content
MedsAcross

Molecule

Ammonium lactate

Acidifying Activity
Available on request
Presentations
2
Brands
0
Manufacturers
0
Available from stock
0

Ammonium lactate is an alpha-hydroxy acid indicated for the treatment of ichthyosis vulgaris and xerosis. It is available as cream and lotion for topical use. MedsAcross supplies Ammonium lactate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Acidifying Activity
US FDA first approval
24 April 1985
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Topical
Dosage forms
Cream, Lotion
Identifiers
UNII 67M901L9NQRxCUI 215247CAS 515-98-0DrugBank DB06768Q663358

Clinical information

From the regulator-approved product information. Each section names its source.

Dosing overview

Apply to the affected areas and rub in thoroughly. Use twice daily or as directed by a physician.

Source: US FDA prescribing information

Contraindications

Ammonium lactate cream is contraindicated in those patients with a history of hypersensitivity to any of the label ingredients.

Source: US FDA prescribing information

Warnings and precautions

WARNING Sun exposure to areas of the skin treated with ammonium lactate cream should be minimized or avoided. The use of ammonium lactate cream should be discontinued if any hypersensitivity is observed.

Source: US FDA prescribing information

Side effects

In controlled clinical trials of patients with ichthyosis vulgaris, the most frequent adverse reactions in patients treated with ammonium lactate cream were rash (including erythema and irritation) and burning/stinging. Each was reported in approximately 10% to 15% of patients. In addition, itching was reported in approximately 5% of patients. In controlled clinical trials of patients with xerosis, the most frequent adverse reactions in patients treated with ammonium lactate cream were transient burning, in about 3% of patients, stinging, dry skin and rash, each reported in approximately 2% of patients.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

2 presentations of Ammonium lactate, sorted by availability.

MedicineManufacturerRegisterAvailability
Ammonium lactate 12% creamTopicalGeneric name—US FDAAvailable on request
Ammonium lactate 12% lotionTopicalGeneric name—US FDAAvailable on request

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 24 April 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Ammonium lactate in public data. This is not a list of approved uses, see the clinical information.

Questions and answers

Is Ammonium lactate available for export from India?

Yes, on request. MedsAcross lists 2 presentations of Ammonium lactate and sources them for licensed hospitals, importers and physicians against valid import documents.

Is Ammonium lactate approved by the US FDA?

Yes. The US FDA first approved Ammonium lactate on 24 April 1985, according to Drugs@FDA.

Does Ammonium lactate need cold chain shipping?

No listed presentation of Ammonium lactate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Ammonium lactate prescribing information (Viona Pharmaceuticals). U.S. National Library of Medicine, DailyMed. Retrieved 2 October 2026

Request Ammonium lactate for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.